NHS Dudley Health Economy Medicines Formulary
Home > 9 Nutrition and blood > 9.1 Anaemias and some other blood disorders > 9.1.4 Drugs used in platelet disorders > Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal) - NICE TAG TA382

Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal) - NICE TAG TA382

NICE is unable to make a recommendation about the use in the NHS of eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy because no evidence submission was received from Novartis for the technology.

https://www.nice.org.uk/guidance/ta382

Site by Devopa
© Copyright 2021 NHS. All rights reserved.